文献速递腹部MR

原发性硬化性胆管炎的风险分层:MRCP胆管狭窄严重程度与MR弹性成像及振动控制瞬时弹性成像肝硬度的比较

Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography.
PubMed 文献 · Eur Radiol · 2020-03-04

本研究对87例原发性硬化性胆管炎患者前瞻性行生化检查、VCTE、MRCP和MRE,比较基于MRCP的胆管狭窄分级、MRE与VCTE肝硬度对Mayo风险评分和Amsterdam Oxford预后指数的判别能力。MRE肝硬度联合肝内狭窄严重程度对Mayo风险评分风险类别判别力较高(AUROC=0.8),MRE肝硬度单独对AOPI风险类别判别力优秀(AUROC=0.9),优于肝内狭窄严重程度(AUROC=0.6-0.7);VCTE肝硬度与狭窄严重程度不相关且无助于区分风险组。

要点

  • MRE肝硬度对AOPI风险类别判别力优秀(AUROC=0.9),优于肝内狭窄严重程度(AUROC=0.6-0.7)。
  • MRE肝硬度联合肝内狭窄严重程度对Mayo风险评分风险类别判别力较高(AUROC=0.8)。
  • VCTE肝硬度与狭窄严重程度不相关,无助于区分风险组。

关键影像表现/征象

  • MRE肝硬度与肝内狭窄严重程度呈弱相关(rho=0.3;p=0.011)。
  • VCTE肝硬度值与狭窄严重程度不相关,无助于区分风险组。

诊断标准与关键数值

  • MRE肝硬度联合肝内狭窄严重程度对Mayo风险评分风险类别的AUROC=0.8。
  • MRE肝硬度单独对AOPI风险类别( cutoff 1和2.7)的AUROC=0.9,优于肝内狭窄严重程度(AUROC=0.6-0.7)。
  • 肝内狭窄严重程度单独判别MRE晚期肝纤维化的AUROC=0.7;联合肝内和肝外狭窄严重程度并控制胆汁淤积和病程后AUROC=0.9。

临床应用与阅片要点

  • MRE肝硬度值对区分早期至中度与晚期肝纤维化有显著判别能力,可能为风险预后增加价值。
  • 作者指出需进一步纳入临床结局的研究。

局限性

  • 原文指出需进一步纳入临床结局的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare biliary stricture severity on magnetic resonance cholangiopancreatography (MRCP), magnetic resonance elastography (MRE), and vibration-controlled transient elastography (VCTE) liver stiffness (LS) for evaluation of risk stratification and prognostication in primary sclerosing cholangitis (PSC).

MATERIALS AND METHODS: Eighty-seven patients (31-61 years; 34 female/53 male) prospectively underwent biochemical testing, VCTE, MRCP, and MRE between January 2014 and July 2016. Correlation between the MRCP grading of PSC based on biliary stricture severity, LS on MRE and VCTE, and the Mayo Risk Score as well as the Amsterdam Oxford Prognostic Index (AOPI) were evaluated and compared. Stricture severity was classified according to previous classification systems based on ERCP. Spearman's correlation and Kruskal-Wallis tests were performed.

RESULTS: MRE-LS and intrahepatic stricture severity combined demonstrated higher discriminatory ability among risk categories based on Mayo Risk Score (AUROC = 0.8). MRE-LS alone demonstrated excellent discriminatory ability among risk categories based on AOPI using cutoffs of 1 and 2.7 and was superior to intrahepatic stricture severity (AUROC = 0.9, AUROC = 0.6-0.7). There was a weak correlation between intrahepatic stricture severity and MRE-LS (rho = 0.3; p = 0.011). VCTE-LS values were not correlated with stricture severity and were noncontributory to differentiate patients across risk groups. Intrahepatic stricture severity alone was a poor discriminator of advanced liver fibrosis on MRE (AUROC = 0.7); however, combining intra- and extrahepatic stricture severity and controlling for cholestasis and disease duration improved results (AUROC = 0.9).

CONCLUSION: This study demonstrates a significant discriminatory ability of LS values on MRE to distinguish between early to moderate and advanced liver fibrosis. LS values on MRE may add value to risk prognostication and further studies including clinical outcomes are needed.

KEY POINTS: • Risk stratification was excellent for liver stiffness measurements on MRE and poor for VCTE and biliary stricture severity. • Risk stratification was further improved when liver stiffness measured on MRE was combined with intrahepatic and extrahepatic stricture severity and indicators of cholestasis were controlled for. • Liver stiffness measurements on MRE correlated with prognostic scores better than measurements performed on VCTE.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Tafur M, Cheung A, Menezes RJ, et al. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography. Eur Radiol. 2020. PMID: 32130494. doi:10.1007/s00330-020-06728-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。